{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T20:05:39Z","timestamp":1780085139197,"version":"3.54.0"},"reference-count":167,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100005671","name":"Funda\u00c3\u00a7\u00c3\u00a3o de Apoio \u00c3\u00a0 Pesquisa e \u00c3\u00a0 Inova\u00c3\u00a7\u00c3\u00a3o Tecnol\u00c3\u00b3gica do Estado de Sergipe","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005671","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00c3\u00adfico e Tecnol\u00c3\u00b3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005639","name":"Universidade de S\u00c3\u00a3o Paulo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005639","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00c3\u00adfico e Tecnol\u00c3\u00b3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00c3\u00a7\u00c3\u00a3o de Amparo \u00c3\u00a0 Pesquisa do Estado de S\u00c3\u00a3o Paulo","doi-asserted-by":"publisher","award":["2017\/26815-1"],"award-info":[{"award-number":["2017\/26815-1"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00c3\u00a7\u00c3\u00a3o de Amparo \u00c3\u00a0 Pesquisa do Estado de S\u00c3\u00a3o Paulo","doi-asserted-by":"publisher","award":["2018\/12119-6"],"award-info":[{"award-number":["2018\/12119-6"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.pnpbp.2020.109878","type":"journal-article","created":{"date-parts":[[2020,1,23]],"date-time":"2020-01-23T11:28:41Z","timestamp":1579778921000},"page":"109878","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Ketamine effects on anxiety and fear-related behaviors: Current literature evidence and new findings"],"prefix":"10.1016","volume":"100","author":[{"given":"Gabriela P.","family":"Silote","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina F.S.","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deidiane E.","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayara S.","family":"Machado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Andreatini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e2mia R.L.","family":"Joca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Beijamini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2020.109878_bb0005","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0031-9384(98)00226-1","article-title":"NMDA receptors mediate lasting increases in anxiety-like behavior produced by the stress of predator exposure - Implications for anxiety associated with posttraumatic stress disorder","volume":"65","author":"Adamec","year":"1998","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.pnpbp.2020.109878_bb0010","doi-asserted-by":"crossref","first-page":"17m11634","DOI":"10.4088\/JCP.17m11634","article-title":"Efficacy, safety, and durability of repeated ketamine infusions for comorbid posttraumatic stress disorder and treatment-resistant depression","volume":"79","author":"Albott","year":"2018","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.pnpbp.2020.109878_bb0015","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/s00213-005-0292-0","article-title":"In vitro and in vivo studies in rats with LY293558 suggest AMPA\/kainate receptor blockade as a novel potential mechanism for the therapeutic treatment of anxiety disorders","volume":"185","author":"Alt","year":"2006","journal-title":"Psychopharmacology (Berl)."},{"key":"10.1016\/j.pnpbp.2020.109878_bb0020","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.nbd.2009.05.012","article-title":"Chronic ketamine impairs fear conditioning and produces long-lasting reductions in auditory evoked potentials","volume":"35","author":"Amann","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.pnpbp.2020.109878_bb0025","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1538\/expanim.60.111","article-title":"Strain and sex differences in anxiety-like and social behaviors in C57BL\/6J and BALB\/cJ mice","volume":"60","author":"An","year":"2011","journal-title":"Exp. Anim."},{"key":"10.1016\/j.pnpbp.2020.109878_bb0030","doi-asserted-by":"crossref","first-page":"e674","DOI":"10.4088\/JCP.17f11681","article-title":"Ketamine for depression, 3: Does chirality matter?","volume":"78","author":"Andrade","year":"2017","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.pnpbp.2020.109878_bb0035","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.brainres.2015.01.001","article-title":"Differential role of AMPA receptors in mouse tests of antidepressant and anxiolytic action","volume":"1601","author":"Andreasen","year":"2015","journal-title":"Brain Res."},{"key":"10.1016\/j.pnpbp.2020.109878_bb0040","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nature10130","article-title":"NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses","volume":"475","author":"Autry","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.pnpbp.2020.109878_bb0045","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.neulet.2016.11.064","article-title":"Glutamate dysregulation and glutamatergic therapeutics for PTSD: evidence from human studies","volume":"649","author":"Averill","year":"2017","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.pnpbp.2020.109878_bb0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0166733","article-title":"The devil is in the details: incomplete reporting in preclinical animal research","volume":"11","author":"Avey","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.pnpbp.2020.109878_bb0055","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0014-2999(01)01340-1","article-title":"Effects of ketamine on different types of anxiety\/fear and related memory in rats with lesions of the median raphe nucleus","volume":"431","author":"Babar","year":"2001","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pnpbp.2020.109878_bb0060","doi-asserted-by":"crossref","first-page":"327","DOI":"10.31887\/DCNS.2015.17.3\/bbandelow","article-title":"Epidemiology of anxiety disorders in the 21st century","volume":"17","author":"Bandelow","year":"2015","journal-title":"Dialogues Clin. Neurosci."},{"key":"10.1016\/j.pnpbp.2020.109878_bb0065","doi-asserted-by":"crossref","first-page":"93","DOI":"10.31887\/DCNS.2017.19.2\/bbandelow","article-title":"Treatment of anxiety disorders","volume":"19","author":"Bandelow","year":"2017","journal-title":"Dialogues Clin. Neurosci."},{"key":"10.1016\/j.pnpbp.2020.109878_bb0070","first-page":"1","article-title":"Efficacy and safety of ketamine in the management of anxiety and anxiety spectrum disorders: a review of the literature","author":"Banov","year":"2019","journal-title":"CNS Spectr."},{"key":"10.1016\/j.pnpbp.2020.109878_bb0075","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0006-3223(99)00230-9","article-title":"Antidepressant effects of ketamine in depressed patients","volume":"47","author":"Berman","year":"2000","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2020.109878_bb0080","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.neulet.2017.08.019","article-title":"A standardization of the novelty-suppressed feeding test protocol in rats","volume":"658","author":"Blasco-Serra","year":"2017","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.pnpbp.2020.109878_bb0085","first-page":"37","article-title":"Putative mechanisms of action of antidepressant drugs in affective and anxiety disorders and pain","volume":"26","author":"Blier","year":"2001","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/j.pnpbp.2020.109878_bb0090","doi-asserted-by":"crossref","first-page":"295","DOI":"10.31887\/DCNS.2015.17.3\/mbourin","article-title":"Animal models for screening anxiolytic-like drugs: a perspective","volume":"17","author":"Bourin","year":"2015","journal-title":"Dialogues Clin. Neurosci."},{"key":"10.1016\/j.pnpbp.2020.109878_bb0095","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.biopsych.2015.04.022","article-title":"Ketamine as a prophylactic against stress-induced depressive-like behavior","volume":"79","author":"Brachman","year":"2016","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2020.109878_bb0100","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/npp.2012.246","article-title":"GLYX-13, a NMDA receptor glycine-site functional partial agonist, induces antidepressant-like effects without ketamine-like side effects","volume":"38","author":"Burgdorf","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2020.109878_bb0105","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1097\/FBP.0000000000000333","article-title":"Effects of systemic glutamatergic manipulations on conditioned eyeblink responses and hyperarousal in a rabbit model of post-traumatic stress disorder","volume":"28","author":"Burhans","year":"2017","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.pnpbp.2020.109878_bb0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fncel.2017.00046","article-title":"Six years of research on the National Institute of Mental Health\u2019s Research Domain Criteria (RDoC) initiative: a systematic review","volume":"11","author":"Carcone","year":"2017","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.pnpbp.2020.109878_bb0115","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.neuropharm.2012.12.009","article-title":"Sex differences in the antidepressant-like effects of ketamine","volume":"70","author":"Carrier","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pnpbp.2020.109878_bb0120","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1093\/ijnp\/pyy053","article-title":"No sex-specific differences in the acute antidepressant actions of (R)-ketamine in an inflammation model","volume":"21","author":"Chang","year":"2018","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.pnpbp.2020.109878_bb0125","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1177\/0269881117748903","article-title":"The effect of ketamine on the consolidation and extinction of contextual fear memory","volume":"32","author":"Clifton","year":"2018","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2020.109878_bb0130","article-title":"Anxiety disorders","volume":"3","author":"Craske","year":"2017","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.pnpbp.2020.109878_bb0135","doi-asserted-by":"crossref","DOI":"10.1111\/j.1476-5381.2011.01362.x","article-title":"The age of anxiety: role of animal models of anxiolytic action in drug discovery","author":"Cryan","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.pnpbp.2020.109878_bb0140","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.bbr.2015.07.017","article-title":"Ketamine induces anxiolytic effects in adult zebrafish: a multivariate statistics approach","volume":"292","author":"De Campos","year":"2015","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.pnpbp.2020.109878_bb0145","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1001\/archgenpsychiatry.2010.90","article-title":"A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression","volume":"67","author":"Diazgranados","year":"2010","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.pnpbp.2020.109878_bb0150","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0025-18.2018","article-title":"Inhibition of a descending prefrontal circuit prevents ketamine-induced stress resilience in females","volume":"5","author":"Dolzani","year":"2018","journal-title":"eNeuro"},{"key":"10.1016\/j.pnpbp.2020.109878_bb0155","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1097\/ALN.0b013e3181ed09a2","article-title":"Taming the ketamine tiger","volume":"113","author":"Domino","year":"2010","journal-title":"Anesthesiology"},{"key":"10.1016\/j.pnpbp.2020.109878_bb0160","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.neuropharm.2017.11.022","article-title":"Behavioral and biochemical sensitivity to low doses of ketamine: Influence of estrous cycle in C57BL\/6 mice","volume":"130","author":"Dossat","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pnpbp.2020.109878_bb0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0137864","article-title":"Does publication bias inflate the apparent efficacy of psychological treatment for major depressive disorder? A systematic review and meta-analysis of US National Institutes of health-funded trials","volume":"10","author":"Driessen","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.pnpbp.2020.109878_bb0170","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.pnpbp.2016.05.007","article-title":"Potential involvement of serotonergic signaling in ketamine\u2019s antidepressant actions: a critical review","volume":"71","author":"du Jardin","year":"2016","journal-title":"Prog. Neuro-Psychopharmacology Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2020.109878_bb0175","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.neuropharm.2016.06.022","article-title":"Prediction of individual differences in fear response by novelty seeking, and disruption of contextual fear memory reconsolidation by ketamine","volume":"109","author":"Duclot","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pnpbp.2020.109878_bb0180","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.neubiorev.2005.03.017","article-title":"Recent advances in animal models of chronic antidepressant effects: The novelty-induced hypophagia test","volume":"29","author":"Dulawa","year":"2005","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.pnpbp.2020.109878_bb0185","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.neuroscience.2009.03.038","article-title":"Anxiolytic- and antidepressant-like properties of ketamine in behavioral and neurophysiological animal models","volume":"161","author":"Engin","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.pnpbp.2020.109878_bb0190","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1001\/jamapsychiatry.2014.62","article-title":"Efficacy of intravenous ketamine for treatment of chronic posttraumatic stress disorder: A randomized clinical trial","volume":"71","author":"Feder","year":"2014","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.pnpbp.2020.109878_bb0195","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.coph.2018.02.004","article-title":"Metabotropic glutamate receptors as targets for novel anxiolytics","volume":"38","author":"Ferraguti","year":"2018","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.pnpbp.2020.109878_bb0200","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1097\/FBP.0000000000000243","article-title":"Positive allosteric modulation of \u03b1-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid glutamate receptors differentially modulates the behavioural effects of citalopram in mouse models of antidepressant and anxiolytic action","volume":"27","author":"Fitzpatrick","year":"2016","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.pnpbp.2020.109878_bb0205","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.neuropharm.2018.05.009","article-title":"Ketamine facilitates extinction of avoidance behavior and enhances synaptic plasticity in a rat model of anxiety vulnerability: implications for the pathophysiology and treatment of anxiety disorders","volume":"137","author":"Fortress","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pnpbp.2020.109878_bb0210","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jpsychires.2018.02.006","article-title":"Anxiolytic effects of ascorbic acid and ketamine in mice","volume":"100","author":"Fraga","year":"2018","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.pnpbp.2020.109878_bb0215","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.neuroscience.2015.01.008","article-title":"Sex differences in the rapid and the sustained antidepressant-like effects of ketamine in stress-na\u00efve and \u201cdepressed\u201d mice exposed to chronic mild stress","volume":"290","author":"Franceschelli","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.pnpbp.2020.109878_bb0220","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/7854_2016_65","article-title":"Animal models of PTSD: a critical review","volume":"38","author":"Frandreau","year":"2017","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"10.1016\/j.pnpbp.2020.109878_bb0225","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1007\/s00213-013-3378-0","article-title":"Serotonin-1A receptor stimulation mediates effects of a metabotropic glutamate 2\/3 receptor antagonist, 2S-2-amino-2-(1S,2S-2-carboxycycloprop-1-yl)- 3-(xanth-9-yl)propanoic acid (LY341495), and an N-methyl-D-aspartate receptor antagonist, ketamine","volume":"231","author":"Fukumoto","year":"2014","journal-title":"Psychopharmacology (Berl)."},{"key":"10.1016\/j.pnpbp.2020.109878_bb0230","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1124\/jpet.116.239228","article-title":"Antidepressant potential of (R) -ketamine in rodent models : comparison with ( S ) -ketamine","volume":"361","author":"Fukumoto","year":"2017","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pnpbp.2020.109878_bb0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nbd.2016.12.026","article-title":"Ketamine accelerates fear extinction via mTORC1 signaling","volume":"100","author":"Girgenti","year":"2017","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.pnpbp.2020.109878_bb0240","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1177\/0269881117705089","article-title":"Ketamine\u2019s dose-related effects on anxiety symptoms in patients with treatment refractory anxiety disorders","volume":"31","author":"Glue","year":"2017","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2020.109878_bb0245","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1177\/0269881118762073","article-title":"Safety and efficacy of maintenance ketamine treatment in patients with treatment-refractory generalised anxiety and social anxiety disorders","volume":"32","author":"Glue","year":"2018","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2020.109878_bb0250","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/nrd4075","article-title":"50 years of hurdles and hope in anxiolytic drug discovery","volume":"12","author":"Griebel","year":"2013","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.pnpbp.2020.109878_bb0255","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.pbb.2017.12.004","article-title":"The effects of ketamine on sexual behavior, anxiety, and locomotion in female rats","volume":"165","author":"Guarraci","year":"2018","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pnpbp.2020.109878_bb0260","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1176\/appi.focus.20160042","article-title":"Anxiety disorders among women: a female lifespan approach","volume":"15","author":"Hantsoo","year":"2017","journal-title":"Focus (Madison)."},{"key":"10.1016\/j.pnpbp.2020.109878_bb0265","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/S0028-3908(03)00030-3","article-title":"Serotonergic mediation of the antidepressant-like effects of nitric oxide synthase inhibitors","volume":"44","author":"Harkin","year":"2003","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pnpbp.2020.109878_bb0270","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.bbr.2017.10.016","article-title":"Animals, anxiety, and anxiety disorders: how to measure anxiety in rodents and why","volume":"352","author":"Harro","year":"2018","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.pnpbp.2020.109878_bb0275","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.pbb.2011.06.014","article-title":"Metabotropic and ionotropic glutamate receptors as neurobiological targets in anxiety and stress-related disorders: focus on pharmacology and preclinical translational models","volume":"100","author":"Harvey","year":"2012","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pnpbp.2020.109878_bb0280","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1471-2202-7-25","article-title":"Behavioral effects of ketamine and toxic interactions with psychostimulants","volume":"7","author":"Hayase","year":"2006","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.pnpbp.2020.109878_bb0285","doi-asserted-by":"crossref","first-page":"949","DOI":"10.3390\/ijms20040949","article-title":"Decoding the mechanism of action of rapid-acting antidepressant treatment strategies: does gender matter?","volume":"20","author":"Herzog","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.pnpbp.2020.109878_bb0290","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.physbeh.2015.05.013","article-title":"Measure of anxiety-related behaviors and hippocampal BDNF levels associated to the amnesic effect induced by MK-801 evaluated in the modified elevated plus-maze in rats","volume":"147","author":"Hill","year":"2015","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.pnpbp.2020.109878_bb0295","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1007\/s00213-016-4256-3","article-title":"Rapamycin blocks the antidepressant effect of ketamine in task-dependent manner","volume":"233","author":"Holubova","year":"2016","journal-title":"Psychopharmacology (Berl)."},{"key":"10.1016\/j.pnpbp.2020.109878_bb0300","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.pnpbp.2018.03.019","article-title":"Applying ketamine to alleviate the PTSD-like effects by regulating the HCN1-related BDNF","volume":"86","author":"Hou","year":"2018","journal-title":"Prog. Neuro-Psychopharmacology Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2020.109878_bb0305","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1073\/pnas.85.4.1307","article-title":"Block of N-methyl-D-aspartate-activated current by the anticonvulsant MK-801: selective binding to open channels","volume":"85","author":"Huettner","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pnpbp.2020.109878_bb0310","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.brainresbull.2006.01.010","article-title":"Dose-response characteristics of ketamine effect on locomotion, cognitive function and central neuronal activity","volume":"69","author":"Imre","year":"2006","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.pnpbp.2020.109878_bb0315","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1176\/appi.ajp.2010.09091379","article-title":"Research Domain Criteria (RDoC): toward a new classification framework for research on mental disorders","volume":"167","author":"Insel","year":"2010","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2020.109878_bb0320","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1089\/jpm.2012.0617","article-title":"Daily oral ketamine for the treatment of depression and anxiety in patients receiving hospice care: a 28-day open-label proof-of-concept trial","volume":"16","author":"Irwin","year":"2013","journal-title":"J. Palliat. Med."},{"key":"10.1016\/j.pnpbp.2020.109878_bb0325","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1038\/npp.2015.100","article-title":"Observation of distressed conspecific as a model of emotional trauma generates silent synapses in the prefrontal-amygdala pathway and enhances fear learning, but ketamine abolishes those effects","volume":"40","author":"Ito","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2020.109878_bb0330","first-page":"892","article-title":"All preclinical trials should be registered in advance in an online registry","volume":"44","author":"Jansen","year":"2014","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.pnpbp.2020.109878_bb0335","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/brb3.749","article-title":"Short- and long-term antidepressant effects of ketamine in a rat chronic unpredictable stress model","volume":"7","author":"Jiang","year":"2017","journal-title":"Brain Behav."},{"key":"10.1016\/j.pnpbp.2020.109878_bb0340","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.euroneuro.2013.08.007","article-title":"Immediate ketamine treatment does not prevent posttraumatic stress responses in an animal model for PTSD","volume":"24","author":"Juven-Wetzler","year":"2014","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.pnpbp.2020.109878_bb0345","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/S0006-3223(01)01110-6","article-title":"Ketamine has equal affinity for NMDA receptors and the high-affinity state of the dopamine D2 receptor [multiple letter]","volume":"49","author":"Kapur","year":"2001","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2020.109878_bb0350","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/S0028-3908(97)00130-5","article-title":"Anxiolytic activity of glycine-B antagonists and partial agonists - No relation to intrinsic activity in the patch clamp","volume":"36","author":"Karcz-Kubicha","year":"1997","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pnpbp.2020.109878_bb0355","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1017\/neu.2014.17","article-title":"Effects of single and combined gabapentin use in elevated plus maze and forced swimming tests","volume":"26","author":"Kilic","year":"2014","journal-title":"Acta Neuropsychiatr."},{"key":"10.1016\/j.pnpbp.2020.109878_bb0360","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0007824","article-title":"Survey of the quality of experimental design, statistical analysis and reporting of research using animals","volume":"4","author":"Kilkenny","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.pnpbp.2020.109878_bb0365","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pbio.1000412","article-title":"Improving bioscience research reporting: the arrive guidelines for reporting animal research","volume":"8","author":"Kilkenny","year":"2010","journal-title":"PLoS Biol."},{"key":"10.1016\/j.pnpbp.2020.109878_bb0370","doi-asserted-by":"crossref","first-page":"423","DOI":"10.31887\/DCNS.2011.13.4\/nkoen","article-title":"Pharmacotherapy of anxiety disorders: a critical review","volume":"13","author":"Koen","year":"2011","journal-title":"Dialogues Clin. Neurosci."},{"key":"10.1016\/j.pnpbp.2020.109878_bb0375","first-page":"1186","article-title":"Ketamine: teaching an old drug new tricks","volume":"87","author":"Kohrs","year":"1998","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.pnpbp.2020.109878_bb0380","doi-asserted-by":"crossref","first-page":"181","DOI":"10.31887\/DCNS.2017.19.2\/wcarlezon","article-title":"Behavioral methods to study anxiety in rodents","volume":"19","author":"Lezak","year":"2017","journal-title":"Dialogues Clin. Neurosci."},{"key":"10.1016\/j.pnpbp.2020.109878_bb0385","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1126\/science.1190287","article-title":"mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists","volume":"329","author":"Li","year":"2010","journal-title":"Science (80-. )"},{"key":"10.1016\/j.pnpbp.2020.109878_bb0390","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.biopsych.2010.12.015","article-title":"Glutamate N-methyl-D-aspartate receptor antagonists rapidly reverse behavioral and synaptic deficits caused by chronic stress exposure","volume":"69","author":"Li","year":"2011","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2020.109878_bb0395","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.1007\/s00213-016-4359-x","article-title":"Betaine enhances antidepressant-like, but blocks psychotomimetic effects of ketamine in mice","volume":"233","author":"Lin","year":"2016","journal-title":"Psychopharmacology (Berl)."},{"key":"10.1016\/j.pnpbp.2020.109878_bb0400","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7573\/dic.212305","article-title":"Ketamine as treatment for post-traumatic stress disorder: a review","volume":"8","author":"Liriano","year":"2019","journal-title":"Drugs Context"},{"key":"10.1016\/j.pnpbp.2020.109878_bb0405","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s00213-015-4128-2","article-title":"Regulation of glutamate transporter 1 via BDNF-TrkB signaling plays a role in the anti-apoptotic and antidepressant effects of ketamine in chronic unpredictable stress model of depression","volume":"233","author":"Liu","year":"2016","journal-title":"Psychopharmacology (Berl)."},{"key":"10.1016\/j.pnpbp.2020.109878_bb0410","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0306-4522(02)00652-8","article-title":"Effects of ketamine and N-methyl-D-aspartate on glutamate and dopamine release in the rat prefrontal cortex: Modulation by a group II selective metabotropic glutamate receptor agonist LY379268","volume":"117","author":"Lorrain","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/j.pnpbp.2020.109878_bb0415","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.brainres.2012.07.046","article-title":"Ketamine reduces neuronal degeneration and anxiety levels when administered during early life-induced status epilepticus in rats","volume":"1474","author":"Loss","year":"2012","journal-title":"Brain Res."},{"key":"10.1016\/j.pnpbp.2020.109878_bb0420","first-page":"1","article-title":"Risk of bias in reports of in vivo research: a focus for improvement","volume":"13","author":"Macleod","year":"2015","journal-title":"PLoS Biol."},{"key":"10.1016\/j.pnpbp.2020.109878_bb0425","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.biopsych.2007.05.028","article-title":"Cellular mechanisms underlying the antidepressant effects of ketamine: role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors","volume":"63","author":"Maeng","year":"2008","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2020.109878_bb0430","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1177\/0023677216652380","article-title":"Ketamine alone or combined with midazolam or dexmedetomidine does not affect anxiety-like behaviours and memory in adult wistar rats","volume":"51","author":"Magalh\u00e3es","year":"2017","journal-title":"Lab. Anim."},{"key":"10.1016\/j.pnpbp.2020.109878_bb0435","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.biopsych.2018.02.011","article-title":"Ventral CA3 activation mediates prophylactic ketamine efficacy against stress-induced depressive-like behavior","volume":"84","author":"Mastrodonato","year":"2018","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2020.109878_bb0440","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD011611.pub2","article-title":"Ketamine and other glutamate receptor modulators for depression in adults","author":"McCloud","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.pnpbp.2020.109878_bb0445","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1038\/npp.2017.19","article-title":"Prophylactic ketamine attenuates learned fear","volume":"42","author":"McGowan","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2020.109878_bb0450","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/tp.2015.66","article-title":"The positive effect on ketamine as a priming adjuvant in antidepressant treatment","volume":"5","author":"Melo","year":"2015","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.pnpbp.2020.109878_bb0455","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/S0006-3223(02)01827-9","article-title":"Validation of a simple, ethologically relevant paradigm for assessing anxiety in mice","volume":"54","author":"Merali","year":"2003","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2020.109878_bb0460","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.euroneuro.2015.01.016","article-title":"Learning from the past and looking to the future: emerging perspectives for improving the treatment of psychiatric disorders","volume":"25","author":"Millan","year":"2015","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.pnpbp.2020.109878_bb0465","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1111\/jnc.14544","article-title":"Subanesthetic ketamine reverses neuronal and astroglial metabolic activity deficits in a social defeat model of depression","volume":"146","author":"Mishra","year":"2018","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pnpbp.2020.109878_bb0470","doi-asserted-by":"crossref","first-page":"1","DOI":"10.11613\/BM.2017.030201","article-title":"Dealing with the positive publication bias: Why you should really publish your negative results","volume":"27","author":"Mlinari\u0107","year":"2017","journal-title":"Biochem. Medica"},{"key":"10.1016\/j.pnpbp.2020.109878_bb0475","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1523\/JNEUROSCI.17-08-02921.1997","article-title":"Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex","volume":"17","author":"Moghaddam","year":"1997","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pnpbp.2020.109878_bb0480","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1093\/ijnp\/pyy032","article-title":"Ketamine effects on EEG during therapy of treatment-resistant generalized anxiety and social anxiety","volume":"21","author":"Mohammad Shadli","year":"2018","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.pnpbp.2020.109878_bb0485","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.neubiorev.2016.04.011","article-title":"Concordance and incongruence in preclinical anxiety models: systematic review and meta-analyses","volume":"68","author":"Mohammad","year":"2016","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.pnpbp.2020.109878_bb0490","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s00441-013-1610-1","article-title":"Modeling panic disorder in rodents","volume":"354","author":"Moreira","year":"2013","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.pnpbp.2020.109878_bb0495","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.bbr.2017.04.048","article-title":"Effects of ketamine, dexmedetomidine and propofol anesthesia on emotional memory consolidation in rats: Consequences for the development of post-traumatic stress disorder","volume":"329","author":"Morena","year":"2017","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.pnpbp.2020.109878_bb0500","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1177\/2045125316631267","article-title":"Ketamine enantiomers in the rapid and sustained antidepressant effects","volume":"6","author":"Muller","year":"2016","journal-title":"Ther. Adv. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2020.109878_bb0505","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.biopsych.2012.06.022","article-title":"Rapid and longer-term antidepressant effects of repeated ketamine infusions in treatment-resistant major depression","volume":"74","author":"Murrough","year":"2013","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2020.109878_bb0510","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1517\/14728214.2015.1049996","article-title":"Emerging drugs for the treatment of anxiety","volume":"20","author":"Murrough","year":"2015","journal-title":"Expert Opin. Emerg. Drugs"},{"key":"10.1016\/j.pnpbp.2020.109878_bb0515","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2018.00758","article-title":"What acute stress protocols can tell us about PTSD and stress-related neuropsychiatric disorders","volume":"9","author":"Musazzi","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.pnpbp.2020.109878_bb0520","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/3-540-28082-0_17","article-title":"Pharmacotherapy of anxiety","volume":"169","author":"Nash","year":"2005","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.pnpbp.2020.109878_bb0525","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1038\/nn.2647","article-title":"Animal models of neuropsychiatric disorders","volume":"13","author":"Nestler","year":"2010","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.pnpbp.2020.109878_bb0530","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1176\/appi.ajp.2015.15040465","article-title":"Ketamine and other NMDA antagonists: early clinical trials and possible mechanisms in depression","volume":"172","author":"Newport","year":"2015","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2020.109878_bb0535","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/0031-9384(94)00235-W","article-title":"Effects of ketamine, a noncompetitive NMDA antagonist, on the acquisition of the lever-press response in rats","volume":"57","author":"Pallar\u00e9s","year":"1995","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.pnpbp.2020.109878_bb0540","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/FBP.0000000000000259","article-title":"Antidepressant, anxiolytic and procognitive effects of subacute and chronic ketamine in the chronic mild stress model of depression","volume":"28","author":"Papp","year":"2017","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.pnpbp.2020.109878_bb0545","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.neuropharm.2016.05.010","article-title":"Ketamine treatment involves medial prefrontal cortex serotonin to induce a rapid antidepressant-like activity in BALB\/cJ mice","volume":"112","author":"Pham","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pnpbp.2020.109878_bb0550","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1016\/j.biopsych.2017.10.020","article-title":"Common neurotransmission recruited in (R,S)-Ketamine and (2R,6R)-Hydroxynorketamine\u2013induced sustained antidepressant-like effects","volume":"84","author":"Pham","year":"2018","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2020.109878_bb0555","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/00001756-200502080-00024","article-title":"Anterior cingulate neurochemistry in social anxiety disorder: 1 H-MRS at 4 T esla","volume":"16","author":"Phan","year":"2005","journal-title":"Neuroreport"},{"key":"10.1016\/j.pnpbp.2020.109878_bb0560","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.pnpbp.2006.02.019","article-title":"Ketamine administration disturbs behavioural and distributed neural correlates of fear conditioning in the rat","volume":"30","author":"Pietersen","year":"2006","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatr."},{"key":"10.1016\/j.pnpbp.2020.109878_bb0565","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1007\/s11064-018-02715-y","article-title":"Effects of anesthetic ketamine on anxiety-like behaviour in rats","volume":"44","author":"Pitsikas","year":"2019","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.pnpbp.2020.109878_bb0570","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2019.112153","article-title":"Rodent ketamine depression-related research: finding patterns in a literature of variability","volume":"376","author":"Polis","year":"2019","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.pnpbp.2020.109878_bb0575","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1007\/s12640-017-9759-0","article-title":"Comparison of the psychopharmacological effects of tiletamine and ketamine in rodents","volume":"32","author":"Popik","year":"2017","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.pnpbp.2020.109878_bb0580","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/9780470942390.mo110176","article-title":"Depression-related behavioral tests","volume":"2","author":"Powell","year":"2012","journal-title":"Curr. Protoc. Mouse Biol."},{"key":"10.1016\/j.pnpbp.2020.109878_bb0585","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0014-2999(03)01272-X","article-title":"The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review","volume":"463","author":"Prut","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pnpbp.2020.109878_bb0590","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/mp.2017.36","article-title":"Identifying fast-onset antidepressants using rodent models","volume":"22","author":"Ramaker","year":"2017","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2020.109878_bb0595","first-page":"2","article-title":"Sustained resolution of panic disorder, agoraphobia, and generalized anxiety disorder with a single ketamine infusion: a case report","volume":"18","author":"Ray","year":"2016","journal-title":"Prim. Care Companion CNS Disord."},{"key":"10.1016\/j.pnpbp.2020.109878_bb0600","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/sj.npp.1301057","article-title":"Ketamine, at a dose that disrupts motor behavior and latent inhibition, enhances prefrontal cortex synaptic efficacy and glutamate release in the nucleus accumbens","volume":"32","author":"Razoux","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2020.109878_bb0605","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/FBP.0000000000000266","article-title":"Investigation of antidepressant-like and anxiolytic-like actions and cognitive and motor side effects of four N-methyl-D-aspartate receptor antagonists in mice","volume":"28","author":"Refsgaard","year":"2017","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.pnpbp.2020.109878_bb0610","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.497","article-title":"A systematic review of reviews on the prevalence of anxiety disorders in adult populations","volume":"6","author":"Remes","year":"2016","journal-title":"Brain Behav."},{"key":"10.1016\/j.pnpbp.2020.109878_bb0615","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.pbb.2011.04.010","article-title":"New perspectives in glutamate and anxiety","volume":"100","author":"Riaza Bermudo-Soriano","year":"2012","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pnpbp.2020.109878_bb0620","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.ntt.2011.05.011","article-title":"Behavioral and physiological effects of acute ketamine exposure in adult zebrafish","volume":"33","author":"Riehl","year":"2011","journal-title":"Neurotoxicol. Teratol."},{"key":"10.1016\/j.pnpbp.2020.109878_bb0625","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.neuropharm.2012.04.032","article-title":"Evidence for involvement of nitric oxide and GABAB receptors in MK-801- Stimulated release of glutamate in rat prefrontal cortex","volume":"63","author":"Roenker","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pnpbp.2020.109878_bb0630","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1124\/jpet.118.251652","article-title":"Sex differences in the pharmacokinetics of low-dose ketamine in plasma and brain of male and female rats","volume":"367","author":"Saland","year":"2018","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pnpbp.2020.109878_bb0635","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.neuropharm.2015.07.037","article-title":"Antidepressant-like effects of ketamine, norketamine and dehydronorketamine in forced swim test: Role of activity at NMDA receptor","volume":"99","author":"Sa\u0142at","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pnpbp.2020.109878_bb0640","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.biopsych.2008.08.014","article-title":"Increased anterior cingulate cortical activity in response to fearful faces: a neurophysiological biomarker that predicts rapid antidepressant response to ketamine","volume":"65","author":"Salvadore","year":"2009","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2020.109878_bb0645","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.neulet.2017.08.026","article-title":"Ketamine promotes increased freezing behavior in rats with experimental PTSD without changing brain glucose metabolism or BDNF","volume":"658","author":"Saur","year":"2017","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.pnpbp.2020.109878_bb0650","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1007\/s00213-019-05219-x","article-title":"The novel methoxetamine analogs N-ethylnorketamine hydrochloride (NENK), 2-MeO-N-ethylketamine hydrochloride (2-MeO-NEK), and 4-MeO-N-ethylketamine hydrochloride (4-MeO-NEK) elicit rapid antidepressant effects via activation of AMPA and 5-HT2 receptors","volume":"236","author":"Sayson","year":"2019","journal-title":"Psychopharmacology (Berl)."},{"key":"10.1016\/j.pnpbp.2020.109878_bb0655","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S0149-7634(01)00060-4","article-title":"Modeling panic attacks","volume":"25","author":"Schenberg","year":"2001","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.pnpbp.2020.109878_bb0660","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1007\/s00213-005-0094-4","article-title":"Effects of peritraumatic ketamine medication on early and sustained posttraumatic stress symptoms in moderately injured accident victims","volume":"182","author":"Sch\u00f6nenberg","year":"2005","journal-title":"Psychopharmacology (Berl)."},{"key":"10.1016\/j.pnpbp.2020.109878_bb0665","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1177\/0269881107082481","article-title":"Ketamine aggravates symptoms of acute stress disorder in a naturalistic sample of accident victims","volume":"22","author":"Sch\u00f6nenberg","year":"2008","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2020.109878_bb0670","doi-asserted-by":"crossref","unstructured":"Sert, N.P. du, Hurst, V., Ahluwalia, A., Alam, S., Avey, M.T., Baker, M., Browne, W.J., Clark, A., Cuthill, I.C., Dirnagl, U., Emerson, M., Garner, P., Holgate, S.T., Howells, D.W., Karp, N.A., Lidster, K., MacCallum, C.J., Macleod, M., Petersen, O., Rawle, F., Reynolds, P., Rooney, K., Sena, E.S., Silberberg, S.D., Steckler, T., W\u00fcrbel, H., 2019. The ARRIVE guidelines 2019: updated guidelines for reporting animal research. bioRxiv 703181. doi:https:\/\/doi.org\/10.1101\/703181","DOI":"10.1101\/703181"},{"key":"10.1016\/j.pnpbp.2020.109878_bb0675","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1007\/BF00433744","article-title":"Hyponeophagia and arousal in rats: Effects of diazepam, 5-methoxy-N,N-dimethyltryptamine, d-amphetamine and food deprivation","volume":"78","author":"Shephard","year":"1982","journal-title":"Psychopharmacology (Berl)."},{"key":"10.1016\/j.pnpbp.2020.109878_bb0680","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/(SICI)1520-6394(1997)5:1<29::AID-DA5>3.0.CO;2-0","article-title":"Acute effects of ketamine in the holeboard, the elevated-plus maze, and the social interaction test in wistar rats","volume":"5","author":"Silvestre","year":"1997","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.pnpbp.2020.109878_bb0685","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1177\/0023677217724823","article-title":"PREPARE: guidelines for planning animal research and testing","volume":"52","author":"Smith","year":"2018","journal-title":"Lab. Anim."},{"key":"10.1016\/j.pnpbp.2020.109878_bb0690","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1037\/bne0000074","article-title":"Oxytocin reduces amygdala activity, increases social interactions and reduces anxiety-like behavior irrespective of NMDAR antagonism","volume":"129","author":"Sobota","year":"2015","journal-title":"Behav. Neurosci."},{"key":"10.1016\/j.pnpbp.2020.109878_bb0695","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0116-15.2016","article-title":"New hippocampal neurons mature rapidly in response to ketamine but are not required for its acute antidepressant effects on neophagia in Rats","volume":"3","author":"Soumier","year":"2016","journal-title":"eNeuro"},{"key":"10.1016\/j.pnpbp.2020.109878_bb0700","doi-asserted-by":"crossref","unstructured":"Stein, D.J., Scott, K.M., Jonge, P. de, Kessler, R.C., 2017. Epidemiology of anxiety disorders: from surveys to nosology and back. Dialogues Clin. Neurosci. 19, 127\u2013136.","DOI":"10.31887\/DCNS.2017.19.2\/dstein"},{"key":"10.1016\/j.pnpbp.2020.109878_bb0705","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1159\/000347090","article-title":"A pilot study of anterior cingulate cortex neurochemistry in adolescents with generalized anxiety disorder","volume":"67","author":"Strawn","year":"2013","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.pnpbp.2020.109878_bb0710","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/npp.2017.194","article-title":"Ketamine for social anxiety disorder: a randomized, placebo-controlled crossover trial","volume":"43","author":"Taylor","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2020.109878_bb0715","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0091-3057(99)00261-0","article-title":"Behavioral effects of acute and chronic imipramine in the elevated T-maze model of anxiety","volume":"65","author":"Teixeira","year":"2000","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pnpbp.2020.109878_bb0720","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.bbr.2016.06.041","article-title":"Repeated ketamine treatment induces sex-specific behavioral and neurochemical effects in mice","volume":"312","author":"Thelen","year":"2016","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.pnpbp.2020.109878_bb0725","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.neuroscience.2018.11.053","article-title":"Sex differences in the temporal neuromolecular and synaptogenic effects of the rapid-acting antidepressant drug ketamine in the mouse brain","volume":"398","author":"Thelen","year":"2019","journal-title":"Neuroscience"},{"key":"10.1016\/j.pnpbp.2020.109878_bb0730","first-page":"24","article-title":"Mind the gap - towards complete and transparent reporting of animal research","volume":"26","author":"Tillmann","year":"2017","journal-title":"Med. Writ."},{"key":"10.1016\/j.pnpbp.2020.109878_bb0735","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1007\/s00213-015-4181-x","article-title":"The nitric oxide donor sodium nitroprusside attenuates recognition memory deficits and social withdrawal produced by the NMDA receptor antagonist ketamine and induces anxiolytic-like behaviour in rats","volume":"233","author":"Trevlopoulou","year":"2016","journal-title":"Psychopharmacology (Berl)."},{"key":"10.1016\/j.pnpbp.2020.109878_bb0740","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1056\/NEJMsa065779","article-title":"Selective publication of antidepressant trials and its influence on apparent efficacy","volume":"358","author":"Turner","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pnpbp.2020.109878_bb0745","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1016\/j.euroneuro.2015.06.012","article-title":"Role of the nitric oxide donor sodium nitroprusside in the antidepressant effect of ketamine in mice","volume":"25","author":"Vogt","year":"2015","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.pnpbp.2020.109878_bb0750","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0031-9384(00)00405-4","article-title":"Strain and gender differences in the behavior of mouse lines commonly used in transgenic studies","volume":"72","author":"V\u00f5ikar","year":"2001","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.pnpbp.2020.109878_bb0755","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.bbr.2015.07.026","article-title":"Peripheral proinflammatory markers associated with ketamine response in a preclinical model of antidepressant-resistance","volume":"293","author":"Walker","year":"2015","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.pnpbp.2020.109878_bb0760","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s12031-014-0277-8","article-title":"Downregulation of neuregulin 1-ErbB4 signaling in parvalbumin interneurons in the rat brain may contribute to the antidepressant properties of ketamine","volume":"54","author":"Wang","year":"2014","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.pnpbp.2020.109878_bb0765","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/00000542-198003000-00008","article-title":"Pharmacology of ketamine isomers in surgical patients","volume":"52","author":"White","year":"1980","journal-title":"Anesthesiologysiology"},{"key":"10.1016\/j.pnpbp.2020.109878_bb0770","doi-asserted-by":"crossref","first-page":"7104","DOI":"10.1073\/pnas.83.18.7104","article-title":"The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist","volume":"83","author":"Wong","year":"1986","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pnpbp.2020.109878_bb0780","doi-asserted-by":"crossref","first-page":"e632","DOI":"10.1038\/tp.2015.136","article-title":"R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects","volume":"5","author":"Yang","year":"2015","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.pnpbp.2020.109878_bb0785","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.biopsych.2017.05.016","article-title":"Mechanistic target of rapamycin\u2013independent antidepressant effects of (R)-ketamine in a social defeat stress model","volume":"83","author":"Yang","year":"2018","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2020.109878_bb0790","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0361-9230(96)00381-4","article-title":"Behavioral validation of the elevated T-maze, a new animal model of anxiety","volume":"44","author":"Zangrossi","year":"1997","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.pnpbp.2020.109878_bb0795","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.neubiorev.2014.03.007","article-title":"Serotonin in anxiety and panic: contributions of the elevated T-maze","volume":"46","author":"Zangrossi","year":"2014","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.pnpbp.2020.109878_bb0800","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/mp.2017.255","article-title":"Mechanisms of ketamine action as an antidepressant","volume":"23","author":"Zanos","year":"2018","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2020.109878_bb0805","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1124\/jpet.115.225664","article-title":"The prodrug 4-chlorokynurenine causes ketamine-like antidepressant effects, but not side effects, by NMDA\/GlycineB-Site inhibition","volume":"355","author":"Zanos","year":"2015","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pnpbp.2020.109878_bb0810","first-page":"1","article-title":"NMDAR inhibition-independent antidepressant actions of ketamine metabolites","author":"Zanos","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.pnpbp.2020.109878_bb0815","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/archpsyc.63.8.856","article-title":"A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression","volume":"63","author":"Zarate","year":"2006","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.pnpbp.2020.109878_bb0820","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.1016\/j.biopsych.2012.10.017","article-title":"Reply to: acute stress symptoms do not worsen in posttraumatic stress disorder and abuse with a single subanesthetic dose of ketamine","volume":"73","author":"Zeng","year":"2013","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2020.109878_bb0825","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.pbb.2013.11.033","article-title":"R(\u2212)-ketamine shows greater potency and longer lasting antidepressant effects than S (+)-ketamine","volume":"116","author":"Zhang","year":"2014","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pnpbp.2020.109878_bb0830","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s00213-014-3697-9","article-title":"Anxiolytic effects of ketamine in animal models of posttraumatic stress disorder","volume":"232","author":"Zhang","year":"2015","journal-title":"Psychopharmacology (Berl)."},{"key":"10.1016\/j.pnpbp.2020.109878_bb0835","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ibror.2019.01.006","article-title":"Effects of subanesthetic intravenous ketamine infusion on neuroplasticity-related proteins in the prefrontal cortex, amygdala, and hippocampus of Sprague-Dawley rats","volume":"6","author":"Zhang","year":"2019","journal-title":"IBRO Reports"},{"key":"10.1016\/j.pnpbp.2020.109878_bb2000","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1016\/j.lfs.2005.09.022","article-title":"Effect of acute and chronic MK-801 administration on extracellular glutamate and ascorbic acid release in the prefrontal cortex of freely moving mice on line with open-field behavior","volume":"78","author":"Zuo","year":"2006","journal-title":"Life Sci."}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584619308371?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584619308371?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T19:50:55Z","timestamp":1759521055000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584619308371"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":167,"alternative-id":["S0278584619308371"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2020.109878","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/793398","asserted-by":"object"}]},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ketamine effects on anxiety and fear-related behaviors: Current literature evidence and new findings","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2020.109878","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109878"}}